Cord blood cells aim to fix Chemo-Caused low platelets
NCT ID NCT07110090
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This early-stage trial is testing a single infusion of cells from umbilical cord blood (called XJ-MK-002) in 16 cancer patients whose platelet counts have dropped due to chemotherapy or other cancer treatments. The main goal is to see if the treatment is safe and tolerable, and to check if it can help raise platelet levels. The study is small and open-label, meaning everyone knows what they are getting, and it uses three different doses to find the safest and most promising one.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
umbilical cord blood megakaryocyte injection (XJ-MK-002)
What this could lead to
If it works, this could offer a new way to treat dangerously low platelet counts caused by cancer treatments, reducing the need for platelet transfusions.
What could go wrong
This is a very early, small Phase 1 trial with only 16 people, so it is primarily testing safety. The treatment may not raise platelets enough, and there could be side effects like allergic reactions or infection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cancer Hospital Chinese Academy of Medical Sciences 17 Panjiayuan Nanli, Chaoyang District
RECRUITINGBeijing, Beijing Municipality, 100021, China